On January 17, 2022, Clinigen Group plc announced that the board of directors of the Company and the board of directors of Triley Bidco Limited have agreed the terms of an increased and final recommended all cash offer for the Company by Triley Bidco Limited. In addition, the Company stated that Triley Bidco Limited will acquire the entire issued and to be issued ordinary share capital of the Company at a price of 925 pence in cash per share. Further, the Company stated that in order to allow all shareholders the proper opportunity to fully consider the increased final offer, the Company board intends to propose that the court meeting and the general meeting, which are due to be held on 18 January 2022, has been adjourned to 8 February 2022.